Benjamin Landry to sell 6,317 HCAT restricted shares (HCAT)

Rhea-AI Filing Summary

Health Catalyst, Inc. Form 144 reports a proposed sale of 6,317 restricted common shares and discloses recent restricted-stock dispositions by Benjamin Landry of 14,387 and 27,425 shares. The filing names Morgan Stanley Smith Barney LLC as the broker and lists 02/26/2026 as the sale date for the planned transaction.

Insights

Equity Securities Analyst

Form 144 shows a small planned restricted‑share sale and recent insider dispositions.

The filing lists a proposed sale of 6,317 restricted common shares with 02/26/2026 as the sale date and identifies Morgan Stanley Smith Barney LLC as the broker. It also records prior restricted‑stock sales by Benjamin Landry of 14,387 and 27,425 shares on 12/01/2025 and 12/05/2025, respectively, with proceeds shown as $41,725.18 and $72,327.95.

These item-level disclosures are routine notices required under the rules for resale of restricted securities. The timing and cash‑flow treatment are set by the listed dates and broker; any trading activity will depend on the holder and broker execution.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC 1 New York Plaza, 38th Floor New York NY 10004	6317	11040.85	70730884	02/26/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/26/2026	Restricted Stock	Health Catalyst, Inc.			6317	02/26/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Benjamin Landry c/o 10897 South River From Parkway #100 South Jordan UT 84095	Restricted Stock	12/01/2025	14387	41725.18
Benjamin Landry c/o 10897 South River From Parkway #100 South Jordan UT 84095	Restricted Stock	12/05/2025	27425	72327.95

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the HCAT Form 144 disclose about proposed sales?

The filing discloses a proposed sale of 6,317 restricted common shares with 02/26/2026 listed as the sale date and Morgan Stanley Smith Barney LLC named as the broker.

Who reported recent restricted‑stock sales for HCAT in this filing?

Benjamin Landry is shown as the reporting holder with restricted‑stock dispositions of 14,387 shares on 12/01/2025 and 27,425 shares on 12/05/2025, with proceeds recorded in the filing.

Does the Form 144 specify proceeds from recent sales?

Yes; the excerpt lists proceeds of $41,725.18 for the 12/01/2025 sale and $72,327.95 for the 12/05/2025 sale attributed to restricted stock dispositions.

Which broker is identified on the HCAT Form 144?

The filing names Morgan Stanley Smith Barney LLC at 1 New York Plaza as the broker associated with the proposed sale and includes the exchange designation NASDAQ in the securities information.